Psychedelics Today

In this episode, Kyle interviews Clinical Psychologist and Founder of the Psychedelic Society of Vermont, Dr. Rick Barnett, from a live event in Burlington, VT this past June. They discuss psychedelics' various contexts of use. www.psychedelicstoday.com

In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule.  www.psychedelicstoday.com

In this episode, Joe interviews Brom Rector: podcaster and founder of Empath Ventures, a venture capital fund that invests in psychedelic medicine startups. They discuss investment, IP, the psychedelic crash, ibogaine, and more. www.psychedelicstoday.com

In this episode, David interviews Founder of the People of Color Psychedelic Collective: Ifetayo Harvey. She talks about the racism of the drug war, the importance of caregiving, and what we can do collectively to make change. www.psychedelicstoday.com

In this episode, Joe interviews Laura Guzmán-Dávalos: 40-year veteran mycologist at the University of Guadalajara, Mexico; and daughter of Gaston Guzman, who most consider the world authority on the genus, Psilocybe.  www.psychedelicstoday.com

In this episode, Kyle interviews Doctors James Fadiman, Sam Gandy; and David Luke. They discuss Fadiman's past research and Gandy and Luke's new paper, "Psychedelics as potential catalysts of scientific creativity and insight." www.psychedelicstoday.com

In this episode, Joe interviews Alex Enchin & Ian-Michael Hébert, MA; Co-Founders of HOLOS, a company building hospitality wellness centers with a strong focus on community, reconnection to nature, and a return to wholeness. www.psychedelicstoday.com

In this episode, Joe interviews Seth Rosenberg: Washington DC-based mycologist and anti-drug war advocate who worked on DC's decriminalization Initiative 81, and who was presumably arrested for purchasing legal plants online.  www.psychedelicstoday.com

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.  www.psychedelicstoday.com

In this episode, Joe interviews transformational coach and guide, Brenna Gebauer; in-person from her parents' RV at this year's Lightning in a Bottle festival, with facilitator and past guest, Mark Haberstroh stopping in too.  www.psychedelicstoday.com

In this episode, David interviews globally-recognized cannabis activist, author, entrepreneur, speaker, podcaster, and “Father of the Legal Cannabis Industry,” Steve DeAngelo; discussing industry, decriminalization, and more! www.psychedelicstoday.com

In this episode, Joe interviews Christopher Koddermann: Co-Founder of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI). He discusses patents, IP, and what needs to be done to reschedule psilocybin.  www.psychedelicstoday.com

In this episode, David interviews Kevin Balktick: Founder & Director of Horizons; one of the world's longest-running psychedelic media and education communities, which is expanding to Portland, Oregon this year with Horizons NW. www.psychedelicstoday.com

In this episode, "Vital Psychedelic Conversations" returns with Kyle interviewing Steve Thayer: psychologist, Clinical Director of Education & Training at Novamind, and co-host of the Psychedelic Therapy Frontiers podcast.  www.psychedelicstoday.com

In this episode, David interviews Susan Beaulieu: Extension Educator at the University of Minnesota Extension, who works with her community (the Anishinaabe people) around intergenerational trauma and community resilience.  www.psychedelicstoday.com

In this episode, Joe interviews Soren Shade: producer of the third season of “Hamilton’s Pharmacopeia" and Co-Founder of Top Tree Herbs, a kratom tea company dedicated to educating people about kratom and normalizing its use. www.psychedelicstoday.com

In this episode, Victoria Dekker debuts, interviewing the CEO of TheraPsil, Spencer Hawkswell, about the charter challenge that effectively sues the Canadian government for ending psilocybin exemptions for end-of-life patients. www.psychedelicstoday.com

In this episode, David interviews Monnica Williams, Ph.D. She discusses the mental health impact communities of color face as a result of racism; and what therapists, clinicians, and researchers can do to improve this paradigm. www.psychedelicstoday.com

In this episode, David interviews Joost Breeksema: Executive Director of the OPEN Foundation, which manages the Interdisciplinary Conference on Psychedelic Research (ICPR) which returns to Amsterdam this September 21-24. www.psychedelicstoday.com

In this episode, Joe interviews Kim Dudine: Chief of Staff at OpenNest Labs and Director of Membership and Strategy at Trailblazers Presents. She discusses the benefits, psychedelic nature, and unifying aspects of cannabis. www.psychedelicstoday.com